Kera Capital Partners Inc. bought a new stake in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 6,680 shares of the real estate investment trust's stock, valued at approximately $245,000.
A number of other hedge funds also recently modified their holdings of OHI. AQR Capital Management LLC increased its position in shares of Omega Healthcare Investors by 430.8% during the 1st quarter. AQR Capital Management LLC now owns 2,862,117 shares of the real estate investment trust's stock worth $108,989,000 after purchasing an additional 2,322,878 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of Omega Healthcare Investors by 3.9% in the first quarter. Vanguard Group Inc. now owns 39,554,886 shares of the real estate investment trust's stock valued at $1,506,250,000 after buying an additional 1,492,904 shares during the period. Invesco Ltd. grew its stake in Omega Healthcare Investors by 122.3% during the first quarter. Invesco Ltd. now owns 2,416,560 shares of the real estate investment trust's stock worth $92,023,000 after purchasing an additional 1,329,324 shares during the period. Nuveen LLC bought a new position in Omega Healthcare Investors in the first quarter worth approximately $42,513,000. Finally, Allspring Global Investments Holdings LLC boosted its holdings in Omega Healthcare Investors by 556.1% in the first quarter. Allspring Global Investments Holdings LLC now owns 1,028,187 shares of the real estate investment trust's stock worth $39,143,000 after acquiring an additional 871,472 shares in the last quarter. Institutional investors and hedge funds own 65.25% of the company's stock.
Wall Street Analysts Forecast Growth
A number of analysts recently commented on OHI shares. Raymond James Financial reiterated an "outperform" rating on shares of Omega Healthcare Investors in a report on Tuesday, September 2nd. Mizuho lifted their price target on Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a "neutral" rating in a research note on Thursday, September 11th. Wells Fargo & Company boosted their target price on Omega Healthcare Investors from $41.00 to $44.00 and gave the company an "overweight" rating in a research note on Wednesday, August 27th. Royal Bank Of Canada upped their target price on Omega Healthcare Investors from $39.00 to $41.00 and gave the stock a "sector perform" rating in a report on Thursday, August 7th. Finally, Scotiabank upped their price target on Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a "sector perform" rating in a research note on Thursday, August 28th. Five research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $43.75.
Get Our Latest Stock Report on OHI
Omega Healthcare Investors Price Performance
Shares of Omega Healthcare Investors stock traded down $0.00 during trading on Friday, reaching $41.74. 601,926 shares of the stock traded hands, compared to its average volume of 2,322,350. The company has a market capitalization of $12.31 billion, a price-to-earnings ratio of 25.78, a P/E/G ratio of 2.18 and a beta of 0.71. The business has a fifty day simple moving average of $40.70 and a two-hundred day simple moving average of $38.37. The company has a debt-to-equity ratio of 0.96, a current ratio of 7.10 and a quick ratio of 7.10. Omega Healthcare Investors, Inc. has a 52-week low of $35.04 and a 52-week high of $44.42.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, beating analysts' consensus estimates of $0.45 by $0.32. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The firm had revenue of $235.60 million during the quarter, compared to the consensus estimate of $248.49 million. During the same quarter last year, the firm earned $0.71 EPS. The firm's revenue for the quarter was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Sell-side analysts expect that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.
Omega Healthcare Investors Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were paid a $0.67 dividend. The ex-dividend date of this dividend was Monday, August 4th. This represents a $2.68 annualized dividend and a yield of 6.4%. Omega Healthcare Investors's dividend payout ratio (DPR) is presently 165.43%.
Insider Buying and Selling at Omega Healthcare Investors
In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the completion of the sale, the director owned 18,654 shares of the company's stock, valued at approximately $749,144.64. The trade was a 11.82% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.50% of the company's stock.
About Omega Healthcare Investors
(
Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Read More

Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.